NEW DELHI: Healthcare chain Apollo HospitalsBSE 0.94 % Enterprise and global medical technology major Medtronic Inc today entered into a partnership to develop a cost-effective and efficient dialysis system in India.
The collaboration will leverage on a technology platform developed by Medtronic, supported with clinical insight from Apollo, envisioning a reduction in cost by 10-20 per cent for patients.
At present, on an average a patient spends about Rs 1,200 to Rs 2,000 for a dialysis.
Medtronic intends to develop and manufacture key components of this hemodialysis system in India which will be ready for commercial launch in 2016, the companies said in a joint statement.
"For the first time Medtronic is developing a product in India. The investments for this will be more than Rs 150 crore. We are establishing an R&D team in India for this," Medtronic Inc Chairman and CEO Omar Ishrak told reporters.
Medtronic is committed to creating technologies that can reduce barriers to treatment, enhance and extend the lives of patients around the world, he added.
"This is a new technology after a long time and we decided on India as a launch ped for the new technology," he added.
In the case of hemodialysis, both the cost and lack of mobility of current systems have made broader access to dialysis treatment difficult and expensive, Ishrak said, adding the company's "system will be portable, affordable".
Commenting on the partnership, Apollo Hospitals Enterprise Managing Director Preetha Reddy said: "Apollo will be providing clinical insights and support to Medtronic."
In India nearly 10 per cent of adults suffer from chronic kidney disease, she added.
The two companies expect that a new portable system would broaden the healthcare providers ability to serve patients from hospital to home, saving costs to the them while increasing the access and efficiency.